Nutrients最新文献

{"title":"Comparing the Effectiveness of Different Dietary Educational Approaches for Carbohydrate Counting on Glycemic Control in Adults with Type 1 Diabetes: Findings from the DIET-CARB Study, a Randomized Controlled Trial.","authors":"Bettina Ewers, Martin Bæk Blond, Jens Meldgaard Bruun, Tina Vilsbøll","doi":"10.3390/nu16213745","DOIUrl":"10.3390/nu16213745","url":null,"abstract":"<p><strong>Background/objectives: </strong>Carbohydrate counting is recommended to improve glycemic control in type 1 diabetes (T1D), but the most effective educational methods are unclear. Despite its benefits, many individuals struggle with mastering carbohydrate counting, leading to inconsistent use and suboptimal glycemic outcomes. This study aimed to compare the effectiveness of two group-based programs with individual dietary counseling (standard care) for glycemic control.</p><p><strong>Methods: </strong>The trial was a randomized, controlled, open-label, parallel-group design. Adults with T1D on multiple daily insulin injections (MDIs) and with glycated hemoglobin A1c (HbA1c) 53-97 mmol/mol were randomly assigned (1:1:1) to basic (BCC), advanced carbohydrate counting (ACC), or standard care. Primary outcomes were the changes in HbA1c or mean amplitude of glycemic excursions (MAGEs) in BCC and ACC versus standard care after six months. Equivalence testing was performed to compare BCC and ACC.</p><p><strong>Results: </strong>Between November 2018 and August 2021, 63 participants were randomly assigned to BCC (N = 20), ACC (N = 21), or standard care (N = 22). After 6 months, HbA1c changed by -2 mmol/mol (95% CI -5 to 0 [-0.2%, -0.5 to 0]) in BCC, -4 mmol/mol (-6 to -1 [-0.4%, -0.6 to -0.1]) in ACC, and -3 mmol/mol (-6 to 0 [-0.3%, -0.6 to 0]) in standard care. The estimated difference in HbA1c compared to standard care was 1 mmol/mol (-3 to 5 [0.1%, -0.3 to 0.5]); <i>p</i> = 0.663 for BCC and -1 mmol/mol (-4 to 3 [-0.1%, -0.4 to 0.3]); <i>p</i> = 0.779 for ACC. For MAGEs, changes were -0.3 mmol/L (-1.5 to 0.8) in BCC, -0.0 mmol/L (-1.2 to 1.1) in ACC, and -0.7 mmol/L (-1.8 to 0.4) in standard care, with differences of 0.4 mmol/L (-1.1 to 1.9); <i>p</i> = 0.590 for BCC and 0.7 mmol/L (-0.8 to 2.1); <i>p</i> = 0.360 for ACC versus standard care. An equivalence in effect between BCC and ACC was found for HbA1c, but not for MAGEs.</p><p><strong>Conclusions: </strong>Group-based education in BCC and ACC did not demonstrate a clear advantage over individualized dietary counseling for overall glycemic control in adults with T1D. Healthcare providers should consider flexible, patient-centered strategies that allow individuals to choose the format that best suits their learning preferences when selecting the most suitable dietary educational approach.</p>","PeriodicalId":19486,"journal":{"name":"Nutrients","volume":"16 21","pages":""},"PeriodicalIF":4.8,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11547945/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142622512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Improvement in Glycolipid Metabolism Parameters After Supplementing Fish Oil-Derived Omega-3 Fatty Acids Is Associated with Gut Microbiota and Lipid Metabolites in Type 2 Diabetes Mellitus.","authors":"Jiayue Xia, Shiyu Yin, Junhui Yu, Jiongnan Wang, Xingyi Jin, Yuanyuan Wang, Hechun Liu, Guiju Sun","doi":"10.3390/nu16213755","DOIUrl":"10.3390/nu16213755","url":null,"abstract":"<p><strong>Background/objectives: </strong>This study aimed to investigate the effects of fish oil-derived omega-3 polyunsaturated fatty acids (omega-3 PUFAs) on gut microbiota and serum lipid metabolites in T2DM.</p><p><strong>Methods: </strong>In a three-month, randomized, double-blind, placebo-controlled study, 110 T2DM patients received either fish oil (<i>n</i> = 55) or corn oil (<i>n</i> = 55) capsules daily. Serum lipids, glycemic parameters, gut microbiota diversity, and lipidomics were assessed.</p><p><strong>Results: </strong>This study found that fish oil-derived omega-3 PUFAs intervention did not significantly lower the fasting plasma glucose levels when compared with the baseline level (<i>p</i> > 0.05). However, serum fasting blood glucose (<i>p</i> = 0.039), glycosylated hemoglobin levels (<i>p</i> = 0.048), HOMA-IR (<i>p</i> = 0.022), total cholesterol (<i>p</i> < 0.001), triglyceride (<i>p</i> = 0.034), LDL cholesterol (<i>p</i> = 0.048), and non-HDL levels (<i>p</i> = 0.046) were significantly lower in the fish oil group compared with the corn oil group after three months of intervention. Also, it altered glycerophospholipid metabolism and gut microbiota. After three months, the fish oil group showed a significantly lower abundance of <i>Desulfobacterota</i> compared with the corn oil control group (<i>p</i> = 0.003), with reduced levels of <i>Colidextribacter</i> (<i>p</i> = 0.002), <i>Ralstonia</i> (<i>p</i> = 0.021), and <i>Klebsiella</i> (<i>p</i> = 0.013). Conversely, the abundance of <i>Limosilactobacillus</i> (<i>p</i> = 0.017), <i>Lactobacillus</i> (<i>p</i> = 0.011), and <i>Haemophilus</i> (<i>p</i> = 0.018) increased significantly. In addition, relevant glycolipid metabolism indicators showed significant correlations with the altered profiles of serum lipid metabolites, intestinal bacteria, and fungi.</p><p><strong>Conclusions: </strong>This study highlights the impact of fish oil-derived omega-3 PUFAs on intestinal microbiota structure and function in patients with type 2 diabetes. The observed decrease in pathogenic bacterial species and the enhancement of beneficial species may have significant implications for gut health and systemic inflammation, both of which are pivotal in managing diabetes. Further research is warranted to comprehensively elucidate the long-term benefits and underlying mechanisms of these microbiota alterations.</p>","PeriodicalId":19486,"journal":{"name":"Nutrients","volume":"16 21","pages":""},"PeriodicalIF":4.8,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11547733/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142625228","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Food Insecurity Is Common in Patients with Inflammatory Bowel Disease and Is Associated with Increased Ultra-Processed Food Intake.","authors":"Stephanie Lauren Gold, David Kohler, Hannah Freid, Natasha Haskey, Maitreyi Raman","doi":"10.3390/nu16213736","DOIUrl":"10.3390/nu16213736","url":null,"abstract":"<p><strong>Background/objectives: </strong>Food insecurity (FI) is defined as the lack of consistent access to enough food for an active and healthy life. FI affects over 30 million Americans and is associated with poor clinical outcomes and impaired quality of life and drives significant health inequities. Despite the rising prevalence of FI and the federal focus on improving access to healthy food, there is a paucity of research on FI in patients with inflammatory bowel disease (IBD). Therefore, the goal of this study was to define FI in a cohort of IBD patients and determine whether FI was associated with changes in dietary patterns, including specifically an increase in ultra-processed food (UPF) consumption in this high-risk patient population.</p><p><strong>Methods: </strong>This was a single-center, retrospective cohort study of patients with a diagnosis of IBD who were 18 years of age or older and who were seen in a nutrition focused clinic. Patients were screened for FI using the Hunger Vital Sign™, a 2-question validated FI screening tool and underwent a 24-h dietary recall. The degree of food processing was assessed using the NOVA Food Classification System.</p><p><strong>Results: </strong>Among 128 patients with IBD, we observed that FI is increasingly prevalent, with 45% of patients reporting difficulty with sufficient grocery access at least \"sometimes\" in the last 12 months and 10% reporting decreased food access \"often\" in the prior year. In addition, the patients at high-risk for FI were significantly more likely to eat NOVA 4 UPFs (54% vs. 27%, <i>p</i> = 0.001) and were significantly less likely to eat NOVA 1 unprocessed foods (32% vs. 61%, <i>p</i> = 0.001) as compared to those not at risk for FI. Finally, only a small percentage of those at highest risk for FI were enrolled in a federal food assistance program for grocery support.</p><p><strong>Conclusions: </strong>The prevalence of FI is increasing in patients with IBD and is associated with reduced dietary quality.</p>","PeriodicalId":19486,"journal":{"name":"Nutrients","volume":"16 21","pages":""},"PeriodicalIF":4.8,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11547406/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142625092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Mitigating Dietary Bisphenol Exposure Through the Gut Microbiota: The Role of Next-Generation Probiotics in Bacterial Detoxification.","authors":"Paulina Emanowicz, Paulina Średnicka, Michał Wójcicki, Marek Roszko, Edyta Juszczuk-Kubiak","doi":"10.3390/nu16213757","DOIUrl":"10.3390/nu16213757","url":null,"abstract":"<p><p>Bisphenols, such as bisphenol A and its analogs, which include bisphenol S, bisphenol F, bisphenol AF, and tetramethyl bisphenol F, are chemical contaminants commonly found in food that raise serious health concerns. These xenobiotics can potentially have harmful effects on human health. The gut microbiota plays a crucial role in metabolizing and neutralizing these substances, which is essential for their detoxification and elimination. Probiotic supplementation has been studied for its ability to modulate the gut microbiota's composition and function, enhancing detoxification processes. Next-Generation Probiotics (NGPs) may exhibit better properties than traditional strains and are designed for targeted action on specific conditions, such as obesity. By modulating inflammatory responses and reducing the secretion of pro-inflammatory cytokines, they can significantly improve host health. Research on NGPs' ability to neutralize obesogenic bisphenols remains limited, but their potential makes this a promising area for future exploration. This review aims to understand the mechanisms of the chemical transformation of bisphenol through its interactions with the gut microbiota and the role of probiotics, particularly NGPs, in these processes. Understanding the interplay between bisphenols, gut microbiota, and NGPs may pave the way for strategies to counteract the negative health effects associated with daily and chronic exposure to bisphenols, which is crucial for food safety and consumer health protection.</p>","PeriodicalId":19486,"journal":{"name":"Nutrients","volume":"16 21","pages":""},"PeriodicalIF":4.8,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11547510/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142624937","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Efficacy of Myricetin Supplementation on Glucose and Lipid Metabolism: A Systematic Review and Meta-Analysis of In Vivo Mice Studies.","authors":"Mihai Babotă, Oleg Frumuzachi, Corneliu Tanase, Andrei Mocan","doi":"10.3390/nu16213730","DOIUrl":"10.3390/nu16213730","url":null,"abstract":"<p><strong>Background/objectives: </strong>Type 2 diabetes mellitus (T2DM) is a disorder characterized by insulin resistance, hyperglycemia, and dyslipidemia. Myricetin, a flavonoid found in various plants, has shown potential anti-diabetic effects in murine studies. This meta-analysis aimed to evaluate the impact of myricetin supplementation on glucose metabolism and lipid profiles in mouse models of metabolic diseases.</p><p><strong>Methods: </strong>A systematic review and meta-analysis were conducted in accordance with PRISMA guidelines (PROSPERO: CRD42024591569). Studies involving mice with metabolic disease models and exclusively using myricetin supplementation were checked across four databases (Embase, Scopus, PubMed, and WoS) until 23rd September 2024. The primary outcomes assessed were blood glucose (BG), insulin levels, triacylglycerol (TAG), total cholesterol (TC), HDL, and LDL. A random-effects model was applied to estimate standardized mean differences (SMD), and SYRCLE's risk-of-bias tool for animal studies was used.</p><p><strong>Results: </strong>Twenty-one studies with 514 mice met the inclusion criteria. Myricetin supplementation significantly reduced BG (SMD = -1.45, CI: -1.91 to -0.99, <i>p</i> < 0.00001, <i>I</i>² = 74%), insulin (SMD = -1.78, CI: -2.89 to -0.68, <i>p</i> = 0.002, <i>I</i>² = 86%), TAG (SMD = -2.60, CI: -3.24 to -1.96, <i>p</i> < 0.00001, <i>I</i>² = 81%), TC (SMD = -1.86, CI: -2.29 to -1.44, <i>p</i> < 0.00001, <i>I</i>² = 62%), and LDL (SMD = -2.95, CI: -3.75 to -2.14, <i>p</i> < 0.00001, <i>I</i>² = 74%). However, the effect on HDL was not statistically significant (SMD = 0.71, CI: -0.01 to 1.43, <i>p</i> = 0.05, <i>I</i>² = 83%).</p><p><strong>Conclusions: </strong>Myricetin supplementation improved glucose metabolism and lipid profiles in mouse models, suggesting its potential as a therapeutic agent for managing T2DM. However, further research is needed to confirm these findings in human studies.</p>","PeriodicalId":19486,"journal":{"name":"Nutrients","volume":"16 21","pages":""},"PeriodicalIF":4.8,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11547919/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142624967","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Influence of Carbohydrate Intake on Different Parameters of Soccer Players' Performance: Systematic Review.","authors":"Marián Pueyo, Iñaki Llodio, Jesús Cámara, Daniel Castillo, Cristina Granados","doi":"10.3390/nu16213731","DOIUrl":"10.3390/nu16213731","url":null,"abstract":"<p><strong>Background: </strong>The objective of this systematic review is to analyze the influence of carbohydrate (CHO) intake on physical and technical aspects, glucose and muscle glycogen levels, fatigue, cognition, and gastrointestinal comfort involved in the performance of soccer players, as well as to examine whether there are any differences between men and women.</p><p><strong>Methods: </strong>A bibliographic search was conducted in PubMed, Web of Science, Scopus, and SportDiscus, resulting in 61 selected articles. The PRISMA recommendations and the Cochrane Handbook for Systematic Reviews guidelines were followed.</p><p><strong>Results: </strong>The results indicate that CHO intake before and during the match improves speed and the number of sprints, attenuates the decrease in shooting accuracy and speed, increases time to fatigue, and enhances cognitive function. There is no consensus on passing, dribbling, jumping, or agility improvements. Glucose levels drop during the first 15 min of the second half without affecting performance.</p><p><strong>Conclusions: </strong>It is recommended that players ingest 6-8 g/kg/d of CHO the day before, a meal with 1-3 g/kg 3-4 h before, and 30-60 g/h during the match. Muscle glycogen drops drastically at the end of the match, remaining low at 48 h. Hence, 1-1.5 g/kg/h is recommended during the first 4 h, starting from the first 20 min. Female soccer players have a similar physical demand to men, and energy availability is low, especially in the post-match periods, as they underestimate their energy expenditure and do not consume enough CHO. Therefore, the recommended guidelines should be followed, individualized, and periodized according to each athlete's energy needs.</p>","PeriodicalId":19486,"journal":{"name":"Nutrients","volume":"16 21","pages":""},"PeriodicalIF":4.8,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11547566/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142625243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Xanthohumol Protects Against Neuronal Excitotoxicity and Mitochondrial Dysfunction in APP/PS1 Mice: An Omics-Based Study.","authors":"Fei-Fei Hu, Shi-Yao Pan, Jin-Yu Chu, Jian-Jun Liu, Ting-Ting Duan, Yu Luo, Wen Zhou, Zhi-Ming Wang, Wei Liu, Yan Zeng","doi":"10.3390/nu16213754","DOIUrl":"10.3390/nu16213754","url":null,"abstract":"<p><p><b>Background</b>: Neuronal excitotoxicity and metabolic decline, which begin in the early stages of Alzheimer's disease (AD), pose challenges for effective amelioration. Our previous work suggested that the natural compound xanthohumol, the most abundant prenylated flavonoid in hops, prevents memory deficits in APP/PS1 mice; however, the underlying mechanisms remain unclear. <b>Methods</b>: This study utilized APP/PS1 mice and cutting-edge omics techniques to investigate the effects of xanthohumol on hippocampal proteome, serum metabolome, and microbiome. <b>Results</b>: Our findings revealed that xanthohumol reduces the postsynaptic overexpression of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid, <i>N</i>-methyl-D-aspartate, and metabotropic glutamate receptors, but enhances ATP synthesis and mitophagy in the young AD hippocampus. Further mechanistic analyses suggested systemic regulatory effects, particularly on the decreasing glutamate synthesis in the blood and intestines of AD mice following xanthohumol administration. <b>Conclusions</b>: These results underscore the potential of xanthohumol in mitigating AD pathology through multifaceted mechanisms, sparking interest and curiosity in its preventive and therapeutic potential in AD.</p>","PeriodicalId":19486,"journal":{"name":"Nutrients","volume":"16 21","pages":""},"PeriodicalIF":4.8,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11548031/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142625191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Male Endurance Athletes: Examination of Energy and Carbohydrate Availability and Hormone Responses.","authors":"Erin M Moore, Clemens Drenowatz, Brittany T Williams, Thaddeus C Brodrick, David F Stodden, Toni M Torres-McGehee","doi":"10.3390/nu16213729","DOIUrl":"10.3390/nu16213729","url":null,"abstract":"<p><strong>Background: </strong>This study investigated the effects of decreased energy availability (EA) and carbohydrate availability (CA) on reproductive and metabolic hormones in male endurance-trained athletes.</p><p><strong>Methods: </strong>Thirteen athletes (age: 26.08 ± 4.3 years; weight: 70.9 ± 6.5 kg; height: 179.9 ± 4.2 cm) participated in two training weeks with varying training volumes (low [LV] and high [HV]). The participants logged their diet and exercise for seven days and provided blood samples to measure hormone levels (Testosterone [T], insulin, leptin, cortisol, and interleukin-6 [IL-6]).</p><p><strong>Results: </strong>Results showed that 46.2% (HV) and 38.5% (LV) of participants were at risk for low EA (≤25 kcal/kg FFM·d-1), while 53.8% (HV) and 69.2% (LV) had low CA (<6 g/kg). Strong positive correlations were found between leptin and body fat percentage (DXABFP) in both weeks (HV: r(11) = 0.88, <i>p</i> < 0.001; LV: r(11) = 0.93, <i>p</i> < 0.001). Moderate correlations were observed between T and DXABFP (r(11) = 0.56, <i>p</i> = 0.05) and negative correlations between leptin and fat intake (r(11) = -0.60, <i>p</i> = 0.03). Regression analyses indicated significant relationships between DXABFP and T (F(1,11) = 4.91, <i>p</i> = 0.049), leptin (HV: F(1,11) = 40.56, <i>p</i> < 0.001; LV: F(1,11) = 74.67, <i>p</i> < 0.001), and cortisol (F(1,11) = 6.69, <i>p</i> = 0.025).</p><p><strong>Conclusions: </strong>These findings suggest that monitoring body composition and macronutrients can be clinically useful for male athletes, especially those without access to blood testing. Ultimately, a greater understanding of health and performance outcomes for male athletes is needed.</p>","PeriodicalId":19486,"journal":{"name":"Nutrients","volume":"16 21","pages":""},"PeriodicalIF":4.8,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11547639/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142624323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Response of One-Carbon Biomarkers in Maternal and Cord Blood to Folic Acid Dose During Pregnancy.","authors":"Jennifer M Fleming, Gisselle Rosa, Victoria Bland, Gail P A Kauwell, Olga V Malysheva, Alleigh Wettstein, Dorothy B Hausman, Lynn B Bailey, Hea Jin Park","doi":"10.3390/nu16213703","DOIUrl":"10.3390/nu16213703","url":null,"abstract":"<p><strong>Background/objectives: </strong>The folate Recommended Daily Allowance (RDA) for pregnant women is 600 μg/day dietary folate equivalents, which is equivalent to approximately 400 μg folic acid. Many prenatal supplements contain much higher doses of folic acid. The body's ability to reduce synthetic folic acid to the metabolically active form may be exceeded with high levels of supplementation. The objective of this double-blinded randomized controlled intervention trial was to determine changes in unmetabolized folic acid and other biomarkers of folate and one-carbon metabolism in maternal and cord blood in response to a folic acid dose commonly found in prenatal supplements (800 μg/day) compared to the dose equivalent of the RDA (400 μg/day).</p><p><strong>Methods: </strong>Healthy pregnant women were randomized and provided supplements from their first prenatal visit (<12 weeks gestation) through delivery. Maternal blood was collected at baseline and delivery. Umbilical cord blood from the mothers was collected at delivery.</p><p><strong>Results: </strong>A repeated measures analysis of variance revealed that there was a significant group supplemental dose effect (<i>p</i> = 0.0225) on serum unmetabolized folic acid concentration in mothers but no difference in cord blood unmetabolized folic acid concentrations between groups. Mixed effects analysis found a significant overall effect of pre-pregnancy BMI (<i>p</i> = 0.0360) and length of previous folic acid supplementation (<i>p</i> = 0.0281) on serum folate concentrations. No treatment effect was seen in RBC folate concentrations. Choline concentrations were higher in cord blood from the 800 μg/day group compared to the 400 μg/day group, but there was no group effect in maternal choline concentrations.</p><p><strong>Conclusions: </strong>The results indicate that folic acid dose during pregnancy affects certain folate and one-carbon biomarkers, and these effects are not consistent between maternal and cord blood. Potential long-term effects of these results on both mothers and offspring are unknown and merit further investigation.</p>","PeriodicalId":19486,"journal":{"name":"Nutrients","volume":"16 21","pages":""},"PeriodicalIF":4.8,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11547940/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142625139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Improvement in Symptoms of Depression and Anxiety and Cardiometabolic Risk Factors in Children and Adolescents with Overweight and Obesity Following the Implementation of a Multidisciplinary Personalized Lifestyle Intervention Program.","authors":"Aikaterini Vourdoumpa, George Paltoglou, Maria Manou, Emilia Mantzou, Penio Kassari, Marina Papadopoulou, Gerasimos Kolaitis, Evangelia Charmandari","doi":"10.3390/nu16213710","DOIUrl":"10.3390/nu16213710","url":null,"abstract":"<p><p><b>Background/Objectives</b>: Childhood obesity is one of the most challenging contemporary public health problems. Children and adolescents with obesity experience multiple psychosocial difficulties, such as low self-esteem, depression, anxiety, and behavioral problems, which persist for a long time. The aim of the study was to assess the effect of a multidisciplinary personalized lifestyle intervention for depressive and anxiety symptoms, as evaluated by psychometric questionnaires, and their effect and association with cardiometabolic parameters in children and adolescents with overweight and obesity before and after the intervention. <b>Methods</b>: Six hundred and eleven (n = 611) children and adolescents (mean age ± SE: 10.39 ± 0.10 years; 51.5% females, 46.6% pubertal) were studied prospectively. Subjects were classified as being obese (50.2%), overweight (33.5%), or having a normal BMI (16.2%) according to IOTF criteria. All participants entered a 1-year lifestyle intervention program; laboratory investigations were obtained at the beginning and end of the study and two psychometric questionnaires were completed, the CDI and SCARED, which evaluate symptoms of depression and anxiety, respectively. <b>Results</b>: Following the lifestyle intervention, a significant decrease was noted in anxiety scores in all subjects and in depression scores in youth with obesity, as well as in adolescents with obesity, while females displayed a reduced response to the intervention. Insulin resistance and metabolic syndrome parameters, cortisol, PRL, and LH concentrations were positive predictors for depressive and anxiety symptoms. <b>Conclusions</b>: The implementation of a multidisciplinary personalized lifestyle intervention program in the management of childhood obesity is associated with a significant decrease in cardiometabolic and psychosocial comorbidities in children with and without excess adiposity. The improvement in mental health is likely mediated by an improvement in energy metabolism with subsequent improvement in neuroinflammation owing to lifestyle changes.</p>","PeriodicalId":19486,"journal":{"name":"Nutrients","volume":"16 21","pages":""},"PeriodicalIF":4.8,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11547602/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142625231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}